News
Bayer seeks US FDA approval for contrast agent, gadoquatrane for contrast-enhanced MRI of the CNS and other body regions: Berlin Wednesday, June 18, 2025, 09:00 Hrs [IST] Bayer an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback